Disc Medicine, Inc

Quick facts

Phase 3 pipeline

• DISC-1459 · Hematology
  DISC-1459 is a hepcidin mimetic that increases hepcidin levels to reduce iron absorption and circulating iron, thereby treating iron overload disorders.

Phase 2 pipeline

• DISC-0974
• DISC-3405

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Disc Medicine, Inc portfolio CI brief
• Disc Medicine, Inc pipeline updates RSS